Ketamine Completed Phase 1 Trials for Schizophrenic Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02935725A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males